Prognostic significance of the neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio for advanced non-small cell lung cancer patients with high PD-L1 tumor expression receiving pembrolizumab

Doran Ksienski, Elaine S. Wai, Deepu Alex, Nicole S. Croteau, Ashley T. Freeman, Angela Chan, Tiffany Patterson, Melissa Clarkson, Leathia Fiorino, Zia Poonja, David Fenton, Sarah Irons, Mary Lesperance